Business Context and Reporting Period
This Form 8-K is a current report filed by Cyclacel Pharmaceuticals, Inc. (not Bio Green Med Solution, Inc.) on June 18, 2013. The filing discloses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the administrative change of the external auditor.
Material Changes
- Dismissal of Auditor: Ernst & Young LLP (E&Y) was dismissed as the independent registered public accounting firm effective June 18, 2013.
- Engagement of New Auditor: McGladrey LLP was engaged as the new independent registered public accounting firm to audit financial statements for the year ended December 31, 2013.
- Audit History: E&Y's reports for the years ended December 31, 2011, and 2012 contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, scope, or accounting principles.
- Disagreements: There were no disagreements with E&Y on accounting principles, practices, or audit scope during the two most recent fiscal years or subsequent interim periods.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk disclosed is the transition of the audit firm, though the company confirmed no prior disagreements with the outgoing firm. E&Y has provided a letter to the SEC agreeing with the statements made in this report.
Investor Verification Checklist
- Verify the rationale for the auditor change, as it is not explicitly detailed beyond the Audit Committee's recommendation.
- Review the letter from Ernst & Young LLP (Exhibit 99.1) for any additional context regarding the dismissal.
- Confirm the status of the 2013 audit engagement with McGladrey LLP.
- Note the discrepancy between the requested company name (Bio Green Med Solution, Inc.) and the actual registrant (Cyclacel Pharmaceuticals, Inc.).